Author's posts
What Can You Do For Your Loved Ones When You’re Dying Of Cancer?
Data always has a face. Here is the advice that people who have struggled with cancer had for others at this year’s Forbes Healthcare Summit.
Glaxo And Pfizer Raise The Question: Should Drug Companies Sell Toothpaste and Chapstick?
“[The] really key thing about this deal is not the value it creates for consumer, but how it unlocks bigger cash flows near term to invest in pharma near term,” says Chief Executive Emma Walmsley.
A Year In, Novartis’ Boss Faces The World
“I need to be engaged in the whole shaping of the broader environment,” Vas Narasimhan says. “I think initially I took more of a wait-and-see approach … but I have to have a voice …”
FDA Names Flatiron Health Executive Amy Abernethy Deputy Commissioner
“She’s a highly regarded thought leader who has held numerous positions of leadership in her fields of interest and distinguished herself for her intellect, her passion for patient care and science, and her collegiality,” Scott Gottlieb, the FDA Commis…
Before He Died, Paul Allen Gifted $125 Million To A New Institute To Study The Immune System
The new institute will study the immune systems of healthy people, those with cancer, and those with autoimmune diseases.
Buzzy Startup 10x Genomics Buys Spatial Transcriptomics In Bet On Genetic Tools
10x Genomics, a buzzy, closely held genetics startup based in Pleasanton, Calif., is purchasing Stockholm-based Spatial Transcriptomics for an undisclosed sum in a bid to add another type of genetic imaging tool to its fast-growing line of products.
GSK Buys Tesaro For $5 Billion In Dramatic Bet On Cancer Genetics
The deal is a dramatic bet that the London-based drug giant can see opportunities connected to the genetics of cancer drugs better than the stock market. It fits into a framework outlined in July by Hal Barron, the widely respected pharma veteran who t…
A Billionaire Vs. Drug Firms; Throwing Pharma Under The Bus; What A Vintage iPhone Means For Healthcare
Yesterday, some of the top minds in healthcare gathered near Columbus Circle in Manhattan for the seventh annual Forbes Healthcare Summit. Here are some highlights.
Loxo And Bayer’s Amazing Drug Has An Expensive Price
In an oral capsule form for adults, Vitrakvi will have a wholesale acquisition cost of $32,800 a month for a 30-day supply of 100 milligram capsules. That’s $393,600 annually.
Is Amarin’s Fish-Oil-Derived Drug A Historic Breakthrough Or Not? It’s Complicated
Welcome to a spirited debate about whether a drug derived from fish oil will change the way doctor’s treat heart disease.
